Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab. Bacigalupo A, Angelucci E, Raiola AM, Varaldo R, et al. Bone Marrow Transplant 2020 Mar 13. pii: 10.1038/s41409-020-0855.

Read + Share

Amedeo Smart

Independent Medical Education

Bacigalupo A, Angelucci E, Raiola AM, Varaldo R, et al. Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab. Bone Marrow Transplant 2020 Mar 13. pii: 10.1038/s41409-020-0855.
PMID: 32203257